ADAP - Adaptimmune Therapeutics plc (ADAP) CEO Adrian Rawcliffe on Q1 2021 Results - Earnings Call Transcript

Adaptimmune Therapeutics plc (ADAP) Q1 2021 Earnings Conference Call May 06, 2021, 09:00 AM ET Company Participants Juli Miller - Senior Director, IR Adrian Rawcliffe - CEO Elliot Norry - Senior VP and Chief Medical Officer Helen Tayton-Martin - Co-Founder and Chief Business Officer Karen Miller - SVP, Pipeline Research John Lunger - Chief Patient Supply Officer Conference Call Participants Marc Frahm - Cowen and Company Nick Abbott - Wells Fargo Tony Butler - Roth Capital Jonathan Chang - SVB Leerink Mara Goldstein - Mizuho Presentation Operator Ladies and gentlemen, thank you for standing by and welcome to Q1 2021 Adaptimmune Earnings Conference Call. At this time all participants are in a listen-only mode. [Operator Instructions] I will now like to hand the conference over to your speaker for today, Juli Miller. You may begin. Juli Miller Good morning and welcome to Adaptimmune's conference call to discuss our first quarter

For further details see:

Adaptimmune Therapeutics plc (ADAP) CEO Adrian Rawcliffe on Q1 2021 Results - Earnings Call Transcript